Unraveling the Effects and Characteristics of Proliferating Tumor and Cytotoxic T Cells in Colorectal Cancer

Tumor cell proliferation is a marker for better prognosis in colorectal cancer. Although proliferating cytotoxic T cells demonstrate stronger prognostic value than nonproliferating cytotoxic T cells, spatial proximity to tumor cells diminishes this difference. These findings provide new insights into the interplay between tumor proliferation, immune response, and patient outcomes in colorectal cancer.

Authors

Institutions

Publication Details

Journal
Clinical Cancer Research
Published
2025-11-07
DOI
https://doi.org/10.1158/1078-0432.ccr-25-2026
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Unraveling the Effects and Characteristics of Proliferating Tumor and Cytotoxic T Cells in Colorectal Cancer

Maarit Ahtiainen, Hanna Elomaa, Ville K. Äijälä, Juha Saarnio et al.
Clinical Cancer Research
Cancer Immunotherapy and Biomarkers
article

Unraveling the Effects and Characteristics of Proliferating Tumor and Cytotoxic T Cells in Colorectal Cancer

Maarit Ahtiainen, Hanna Elomaa, Ville K. Äijälä, Juha Saarnio, Olli Helminen, Tero Rautio, Jan Böhm, Erkki‐Ville Wirta, Toni T. Seppälä, Meeri Kastinen, Markus J. Mäkinen, Päivi Sirniö, Vesa‐Matti Pohjanen, Jukka‐Pekka Mecklin, Jouni Härkönen, Henna Karjalainen, Jukka M. J. Rintala, Juha P. Väyrynen, Anne Tuomisto, Vilja V. Tapiainen, Sanna Meriläinen, Onni Sirkiä
article en

Abstract

Tumor cell proliferation is a marker for better prognosis in colorectal cancer. Although proliferating cytotoxic T cells demonstrate stronger prognostic value than nonproliferating cytotoxic T cells, spatial proximity to tumor cells diminishes this difference. These findings provide new insights into the interplay between tumor proliferation, immune response, and patient outcomes in colorectal cancer.

Clinical Cancer ResearchVol. 32(2)
University of Helsinki (FI), Tampere University (FI), University of Eastern Finland (FI), Oulu University Hospital (FI), Helsinki University Hospital (FI), Tampere University Hospital (FI), Tampere University (FI), Central Finland Health Care District (FI), University of Jyväskylä (FI), University of Oulu (FI)
Suomen Lääketieteen Säätiö, Emil Aaltosen Säätiö, Oulun Yliopisto, Sigrid Juséliuksen Säätiö, Syöpäsäätiö, Biocenter Finland, Biocenter, University of Oulu
Openalex Percentile: Top 55%
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.